Literature DB >> 9540159

Can expression of CD95 (Fas/APO-1) ligand on grafts or tumor cells prevent their rejection?

J Allison1, K Seino, H Yagita.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9540159     DOI： 10.1007/BF00787228

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  59 in total

1.  Differentiation of first- and second-set grafts of embryonic, neonatal and adult testis implanted beneath the kidney capsule of adult rat hosts.

Authors:  J H LARKIN
Journal:  Am J Anat       Date:  1960-01

Review 2.  The molecular biology of apoptosis.

Authors:  D L Vaux; A Strasser
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

Review 3.  Role of Fas ligand (CD95L) in immune escape: the tumor cell strikes back.

Authors:  P R Walker; P Saas; P Y Dietrich
Journal:  J Immunol       Date:  1997-05-15       Impact factor: 5.422

4.  Human lung carcinomas express Fas ligand.

Authors:  G A Niehans; T Brunner; S P Frizelle; J C Liston; C T Salerno; D J Knapp; D R Green; R A Kratzke
Journal:  Cancer Res       Date:  1997-03-15       Impact factor: 12.701

5.  The role of Fas in autoimmune diabetes.

Authors:  A V Chervonsky; Y Wang; F S Wong; I Visintin; R A Flavell; C A Janeway; L A Matis
Journal:  Cell       Date:  1997-04-04       Impact factor: 41.582

6.  Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?

Authors:  P Saas; P R Walker; M Hahne; A L Quiquerez; V Schnuriger; G Perrin; L French; E G Van Meir; N de Tribolet; J Tschopp; P Y Dietrich
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

7.  Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells.

Authors:  F Leithäuser; J Dhein; G Mechtersheimer; K Koretz; S Brüderlein; C Henne; A Schmidt; K M Debatin; P H Krammer; P Möller
Journal:  Lab Invest       Date:  1993-10       Impact factor: 5.662

8.  Fetal and postnatal testis shows immunoprivilege as donor tissue.

Authors:  M B Statter; R P Foglia; D E Parks; P K Donahoe
Journal:  J Urol       Date:  1988-01       Impact factor: 7.450

9.  Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.

Authors:  T Takahashi; M Tanaka; C I Brannan; N A Jenkins; N G Copeland; T Suda; S Nagata
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

10.  Metalloproteinase-mediated release of human Fas ligand.

Authors:  N Kayagaki; A Kawasaki; T Ebata; H Ohmoto; S Ikeda; S Inoue; K Yoshino; K Okumura; H Yagita
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.